Revenue
$4.98B
Fiscal year ended 2026-06-30Operating income
$663.00M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30BECTON DICKINSON & CO (BDX) reported revenue of $4.98B and net income of $377.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from BECTON DICKINSON & CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.98B | $4.71B | $5.25B | $8.30B | $4.73B | $4.48B | $5.17B | $5.44B | $4.99B | $5.04B |
| Cost of revenue | $2.67B | $2.56B | $2.84B | $4.27B | $2.49B | $2.62B | $2.93B | $2.95B | $2.68B | $2.74B |
| Gross profit | $2.32B | $2.15B | $2.41B | $4.03B | $2.24B | $1.86B | $2.24B | $2.49B | $2.31B | $2.30B |
| Operating income | $663.00M | $93.00M | $552.00M | $1.17B | $739.00M | $383.00M | $453.00M | $622.00M | $602.00M | $734.00M |
| Net income | $377.00M | -$311.00M | $382.00M | $493.00M | $574.00M | $308.00M | $303.00M | $400.00M | $487.00M | $537.00M |
| Research & development | $258.00M | $249.00M | $306.00M | $559.00M | $230.00M | $232.00M | $343.00M | $302.00M | $299.00M | $299.00M |
| Weighted-average diluted shares | shares 275.16M | shares 280.64M | shares 285.84M | Unavailable | shares 287.22M | shares 287.74M | shares 290.39M | Unavailable | shares 290.25M | shares 290.34M |
| Pretax income | $554.00M | $39.00M | $393.00M | $975.00M | $569.00M | $201.00M | $306.00M | $514.00M | $500.00M | $633.00M |
| Income tax expense | $102.00M | $76.00M | $11.00M | $52.00M | $118.00M | $43.00M | $3.00M | $114.00M | $13.00M | $96.00M |
| Diluted EPS | $1.37 | $-1.11 | $1.34 | Unavailable | $2.00 | $1.07 | $1.04 | Unavailable | $1.68 | $1.85 |
| Selling, general & administrative | $1.26B | $1.21B | $1.39B | $1.84B | $1.16B | $1.12B | $1.32B | $1.26B | $1.20B | $1.19B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $708.00M | $813.00M | $740.00M | $567.00M | $735.00M | $667.00M | $711.00M | $1.72B | $4.46B | $2.35B |
| Total assets | $50.73B | $50.83B | $54.84B | $55.32B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B |
| Current assets | $8.14B | $8.01B | $9.19B | $9.26B | $9.00B | $8.67B | $8.66B | $10.47B | $12.21B | $10.34B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $9.40B | $8.51B | $8.76B | $8.31B | $8.16B | $7.69B | $7.66B | $8.96B | $6.60B | $7.33B |
| Total equity incl. NCI | $24.42B | $24.13B | $25.28B | $25.39B | $25.47B | $25.24B | $25.20B | $25.89B | $25.87B | $25.65B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $3.32B | $3.36B | $4.08B | $3.15B | $3.95B | $3.72B | $3.86B | $3.84B | $3.26B | $3.23B |
| Accounts receivable | $2.36B | $2.20B | $2.51B | $2.40B | $2.94B | $3.03B | $2.64B | $3.03B | $2.60B | $2.56B |
| Goodwill | $25.94B | $25.96B | $26.62B | $25.96B | $26.60B | $26.44B | $26.33B | $26.46B | $24.55B | $24.57B |
| Long-term debt | $13.51B | $14.71B | $16.92B | $17.62B | $17.53B | $17.67B | $17.44B | $17.94B | $18.13B | $16.00B |
| Accounts payable | Unavailable | Unavailable | Unavailable | $1.97B | Unavailable | Unavailable | Unavailable | $1.90B | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | Unavailable | Unavailable | $657.00M | Unavailable | Unavailable | Unavailable | $693.00M | Unavailable | Unavailable | Unavailable |
| Capital expenditures | $143.00M | $125.00M | $108.00M | $377.00M | $164.00M | $114.00M | $105.00M | $296.00M | $179.00M | $134.00M |
| Investing cash flow | Unavailable | Unavailable | -$183.00M | -$494.00M | -$336.00M | -$192.00M | $204.00M | -$3.94B | -$288.00M | -$1.06B |
| Financing cash flow | Unavailable | Unavailable | -$302.00M | -$809.00M | -$841.00M | -$39.00M | -$1.93B | $124.00M | $1.12B | $1.70B |
| Net change in cash | -$152.00M | $64.00M | $174.00M | $60.00M | $46.00M | -$68.00M | -$1.04B | -$2.63B | $2.09B | $1.16B |
| Stock-based compensation | $55.00M | $58.00M | $91.00M | $79.00M | $48.00M | $41.00M | $90.00M | $51.00M | $53.00M | $60.00M |
| Common dividends paid | $286.00M | $290.00M | $299.00M | Unavailable | $299.00M | $298.00M | $302.00M | Unavailable | $275.00M | $275.00M |
| Common share repurchases | $0 | $2.00B | $250.00M | $250.00M | $0 | $0 | $750.00M | $0 | $0 | $0 |
| Depreciation & amortization | $564.00M | $563.00M | $614.00M | $756.00M | $575.00M | $567.00M | $607.00M | $586.00M | $568.00M | $571.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | $549.00M | Unavailable | Unavailable | Unavailable | $588.00M | Unavailable | Unavailable | Unavailable |
| Gross margin | 46.5% | 45.7% | 45.9% | 48.6% | 47.3% | 41.5% | 43.2% | 45.7% | 46.2% | 45.7% |
| Operating margin | 13.3% | 2.0% | 10.5% | 14.1% | 15.6% | 8.5% | 8.8% | 11.4% | 12.1% | 14.5% |
| FCF margin | Unavailable | Unavailable | 10.5% | Unavailable | Unavailable | Unavailable | 11.4% | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.1% | 1.2% | 1.7% | 1.0% | 1.0% | 0.9% | 1.7% | 0.9% | 1.1% | 1.2% |
| Current ratio | 0.87x | 0.94x | 1.05x | 1.11x | 1.10x | 1.13x | 1.13x | 1.17x | 1.85x | 1.41x |
| Revenue YoY growth | 5.4% | 5.2% | 1.6% | 52.7% | -5.3% | -11.2% | 9.8% | 6.9% | 2.3% | 4.6% |
| Net margin | 7.6% | -6.6% | 7.3% | 5.9% | 12.1% | 6.9% | 5.9% | 7.4% | 9.8% | 10.6% |
| R&D / revenue | 5.2% | 5.3% | 5.8% | 6.7% | 4.9% | 5.2% | 6.6% | 5.6% | 6.0% | 5.9% |
| CapEx / revenue | 2.9% | 2.7% | 2.1% | 4.5% | 3.5% | 2.5% | 2.0% | 5.4% | 3.6% | 2.7% |
| Long-term debt / equity | 0.55x | 0.61x | 0.67x | 0.69x | 0.69x | 0.70x | 0.69x | 0.69x | 0.70x | 0.62x |
| Effective tax rate | 18.4% | 194.9% | 2.8% | 5.3% | 20.7% | 21.4% | 1.0% | 22.2% | 2.6% | 15.2% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BDX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-Q · Filed 2026-02-09View SEC filing
10-K · Filed 2025-11-25View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-01View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.